| 1 |
32861229 | Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context. | 2022 Apr 1 |
1 |
| 2 |
34551215 | Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes. | 2022 Mar |
3 |
| 3 |
35591905 | Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea. | 2022 |
1 |
| 4 |
33251697 | Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study. | 2021 Jul |
1 |
| 5 |
33462295 | Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques. | 2021 Jan 18 |
2 |
| 6 |
33544355 | Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study. | 2021 Mar |
5 |
| 7 |
33544356 | Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study. | 2021 Mar |
4 |
| 8 |
33592769 | Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS. | 2021 Apr 1 |
1 |
| 9 |
33719017 | A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease. | 2021 May |
1 |
| 10 |
33776458 | A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose. | 2021 |
1 |
| 11 |
31984772 | [Extreme long duration of type 1 diabetes mellitus]. | 2020 Feb |
1 |
| 12 |
32386349 | Urinary detection of rapid-acting insulin analogs in healthy humans. | 2020 Nov |
1 |
| 13 |
32478645 | Long-term stability of insulin glulisine loaded nanoparticles formulated using an amphiphilic cyclodextrin and designed for intestinal delivery. | 2020 Jul |
3 |
| 14 |
32738019 | Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine? | 2020 Nov |
1 |
| 15 |
31096094 | Identification of recombinant human insulin and biosynthetic insulin analogues by multiplexed targeted unlabeled mass spectrometry of proteotypic tryptic peptides. | 2019 Aug 5 |
1 |
| 16 |
31376619 | The quaternary structure of insulin glargine and glulisine under formulation conditions. | 2019 Oct |
2 |
| 17 |
29316176 | Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: A randomized, phase IV study. | 2018 May |
2 |
| 18 |
29462782 | Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues. | 2018 May 10 |
1 |
| 19 |
30063113 | d-Polyarginine Lipopeptides as Intestinal Permeation Enhancers. | 2018 Oct 8 |
2 |
| 20 |
30545262 | [Effectiveness of one-year insulin glargine and insulin glulisine basal-bolus treatment in people with type 2 diabetes. An analysis from drug reimbursement perspective]. | 2018 Dec |
4 |
| 21 |
30556900 | Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. | 2018 Dec 17 |
1 |
| 22 |
28762200 | Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation. | 2017 Nov |
1 |
| 23 |
25865292 | Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. | 2016 Jan |
4 |
| 24 |
26838553 | A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine. | 2016 Oct |
1 |
| 25 |
27026836 | Immune Thrombocytopenic Purpura and Gastritis by H. pylori Associated With Type 1 Diabetes Mellitus. | 2016 Feb 24 |
1 |
| 26 |
27145344 | Safety of insulin analogues as compared with human insulin in pregnancy. | 2016 Jul |
1 |
| 27 |
27168767 | Access to medicines for diabetes treatment in Brazil: evaluation of "health has no price" program. | 2016 |
2 |
| 28 |
29159123 | Pharmacokinetics and pharmacodynamics of insulin glargine-insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals. | 2016 Mar |
3 |
| 29 |
30603298 | A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion. | 2016 Dec |
2 |
| 30 |
25238698 | Advantage of insulin glulisine over regular insulin in patients with type 2 diabetes and severe renal insufficiency. | 2015 Mar |
4 |
| 31 |
25621137 | Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes. | 2015 Jan |
2 |
| 32 |
25739586 | Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes. | 2015 |
2 |
| 33 |
25788506 | Comparative efficacy and safety of insulin analogs in hospitalized adults. | 2015 Apr 1 |
1 |
| 34 |
26121460 | BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA. | 2015 Jul |
1 |
| 35 |
26568812 | Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus. | 2015 Nov |
1 |
| 36 |
29632561 | Insulin Glulisine in Pregnancy - Experience from Clinical Trials and Post-marketing Surveillance. | 2015 Apr |
5 |
| 37 |
24033863 | Composite efficacy parameters and predictors of hypoglycaemia in basal-plus insulin therapy--a combined analysis of 713 type 2 diabetic patients. | 2014 Mar |
1 |
| 38 |
24639403 | Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients. | 2014 Nov |
2 |
| 39 |
24855159 | Insulin analogs-are they worth it? Yes! | 2014 Jun |
3 |
| 40 |
24855160 | Insulin analogs--is there a compelling case to use them? No! | 2014 Jun |
3 |
| 41 |
24909933 | Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature. | 2014 Aug |
3 |
| 42 |
24949654 | Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin. | 2014 Oct |
4 |
| 43 |
25054310 | Safety results from OCAPI: a European Observational Cohort Study of insulin glulisine-treated children aged 6-12 years with type 1 diabetes. | 2014 Oct |
4 |
| 44 |
25282010 | Evolution of insulin: from human to analog. | 2014 Oct |
1 |
| 45 |
23047542 | Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine. | 2013 |
2 |
| 46 |
23425652 | Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections. | 2013 Jul-Aug |
3 |
| 47 |
24265369 | Insulin glulisine may cause a disease resembling insulin autoimmune syndrome: case report. | 2013 Dec |
1 |
| 48 |
24351186 | Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review. | 2013 Nov 1 |
1 |
| 49 |
30349602 | Incidence of Hypoglycaemia in Patients with Type 2 Diabetes - A Subgroup Analysis from the GINGER study. | 2013 Mar |
5 |
| 50 |
20963448 | Generalized allergy due to zinc in insulin treated with zinc-free insulin. | 2012 Jun |
1 |